A quality-control driven framework using multiple AI algorithms for robust decision making in MRI and mission-critical AI
A method using multiple AI algorithms to enhance the robustness of data processing.
Home>Pharma/Biopharma
ShMOLLI: Shortened Modified Look-Locker Inversion Recovery, for T1 mapping in cardiovascular MRI
An efficient method that generates immediate, high-resolution T1-maps for quantitative cardiac imaging in a short breath-hold with high precision.
A process for enzymatic oxidation of vitamin D to a more bioavailable form for improved supplementation
A process for enzymatic oxidation of vitamin D to a more bioavailable form for improved supplementation
Regulatory B cell immunotherapy
The generation of human regulatory B cell therapy and novel drug targets to improve outcomes in transplantation, autoimmunity and cancer.
Remote activation and delivery of tissue-specific chemotherapy drugs
Nanoparticle bound thermo-responsive polymers enabling a temporal and spatial controlled delivery of chemotherapy drugs for effective cancer treatment.
Rapid high precision microencapsulation for controlled release
A microfluidic hydrogel pre-encapsulation method of making coated hydrogel beads.
Stabilised class III viral fusion proteins for more effective immunisation of rabies disease
Stabilised viral fusion proteins for improved vaccines and protective antibodies against human and veterinary pathogens.
Computational antibody modelling and prediction platform
Oxford researchers have encompassed SAbDab/SAbPred tools, for structural antibody modelling and prediction, into a virtual machine for unified and environment-agnostic use.
Base editing proteins to repair mutations in the haemoglobin gene
Programmable base editing proteins for gene editing therapy which offers a safer and effective approach to treat thalassaemia and sickle cell disease.
Targeted drug delivery to the brain for treating neurodegenerative diseases
Novel drug delivery vehicles capable of directly targeting areas of the brain affected by abnormal tau aggregation, in diseases such as Alzheimer’s disease.
© Oxford University Innovation